Toxicology of Frequently Encountered Nonsteroidal Anti-Inflammatory Drugs in Dogs and Cats

Veterinary Clinics of North America - Small Animal Practice

Volumn 42, Issue 2, 2012, Pages 289-306

  Khan, Safdar A ^a   McLean, Mary Kay ^a  

^a ASPCA ANIMAL POISON CONTROL CENTER   (United States)

Author keywords

Cats; Dogs; Incidents; NSAIDs; Toxicology

Indexed keywords

ACETIC ACID DERIVATIVE; ACETYLSALICYLIC ACID; ACTIVATED CARBON; CARBOXYLIC ACID DERIVATIVE; CIMETIDINE; CYCLOOXYGENASE 2 INHIBITOR; DERACOXIB; DICLOFENAC; ENOLIC ACID DERIVATIVE; ESOMEPRAZOLE; ETODOLAC; FAMOTIDINE; FENAMIC ACID DERIVATIVE; IBUPROFEN; INDOMETACIN; MELOXICAM; MISOPROSTOL; NABUMETONE; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; OXICAM DERIVATIVE; PANTOPRAZOLE; PIROXICAM; PROPIONIC ACID DERIVATIVE; PROSTAGLANDIN; RANITIDINE; SALICYLIC ACID; SUCRALFATE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL HEALTH; CAT; DISEASE ASSOCIATION; DOG; DRUG ABSORPTION; DRUG CLASSIFICATION; DRUG DISTRIBUTION; DRUG DOSE INCREASE; DRUG EXCRETION; DRUG INDUCED DISEASE; DRUG INTOXICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG OVERDOSE; DRUG SAFETY; DRUG USE; FLUID THERAPY; GASTROINTESTINAL IRRITATION; INCIDENCE; KIDNEY FUNCTION; NEPHROTOXICITY; NONHUMAN; PATHOPHYSIOLOGY; PATIENT MONITORING; PROSTAGLANDIN SYNTHESIS; REVIEW; STOMACH DISEASE; STOMACH LAVAGE; STOMACH PROTECTION; STOMACH ULCER; TREATMENT CONTRAINDICATION; TREATMENT INDICATION; TREATMENT RESPONSE; VETERINARY MEDICINE; VOMITING;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CAT DISEASES; CATS; DOG DISEASES; DOGS; INCIDENCE; POISON CONTROL CENTERS; POISONING;

CANIS FAMILIARIS;

EID: 84857560652     PISSN: 01955616     EISSN: 18781306     Source Type: Journal    
DOI: 10.1016/j.cvsm.2012.01.003     Document Type: Review

References (66)

1. Donovan J.W. Nonsteroidal anti-inflammatory drugs and colchicine. Clinical management of poisoning and drug overdose 1998, 687-699. WB Saunders, Philadelphia. 3rd edition. L.M. Haddad, M.W. Shannon, J.F. Winchester (Eds.).
2. Holubek W. Nonsteroidal anti-inflammatory drugs. Goldfrank's toxicologic emergencies 2011, 528-536. McGraw-Hill, New York. 9th edition. L.S. Nelson, R.S. Hoffman, N.A. Lewin (Eds.).
3. Bryson P.D. Nonsteroidal anti-inflammatory agents. Comprehensive review in toxicology for emergency clinicians 1996, 565-575. Taylor and Francis, Washington, DC. 3rd edition.
4. Ellenhorn M.J. Nonsteroidal antiinflammatory drugs. Ellenhorn's medical toxicology: diagnosis and treatment of human poisoning 1997, 196-206. Williams & Wilkins, Baltimore. 2nd edition.
5. Forrester S.D., Troy G.C. Renal effects of nonsteroidal antiinflammatory drugs. Compend Cont Educ 1999, 21:910-919.
6. Johnston S.A., Fox S.M. Mechanisms of action of anti-inflammatory medications used for the treatment of osteoarthritis. JAVMA 1997, 210:1486-1492.
7. Lees P., May S.A., McKeller Q.A. Pharmacology and therapeutics of non-steroidal anti-inflammatory drugs in the dog and cat: I. General pharmacology. J Small Anim Pract 1991, 32:183-193.
8. MacAllister C.G. Nonsteroidal anti-inflammatory drugs: their mechanism of action and clinical uses in horses. Vet Med 1994, 237-240. March.
9. Wolfe M.M. NSAIDs and the gastrointestinal mucosa. Hosp Pract 1996, December 15:37-48.
10. 1 analog as a gastric protectant against aspirin-induced hemorrhage in the dog. J Am Anim Hosp Assoc 1996, 32:401-407.
11. Rubin S.I. Nonsteroidal antiinflammatory drugs, prostaglandins, and the kidney. JAVMA 1986, 188:1065-1068.
12. Kore A.M. Toxicology of nonsteroidal anti-inflammatory drugs. Vet Clin N Am Small Anim Pract 1990, 20:419-430.
13. Dunayer E. Ibuprofen toxicosis in dogs, cats, and ferrets. Vet Med 2004, 580-585. July.
14. Ibuprofen. American Hospital Formulary Service drug information 2000, 1815. American Society of Healthsystem Pharmacists Inc., Bethesda (MD). G.K. McEvoy (Ed.).
15. Kore A.M. Toxicology of nonsteroidal anti-inflammatory drugs. Vet Clin North Am Small Anim Pract 1990, 20:419-428.
16. Rumack BH, et al, editors. Ibuprofen (toxicologic managements). Poisindex System Vol 100. Englewood (CO): Micromedex. Expires 9/2000.
17. Roush J.K. Diseases of joints and ligaments. The handbook of small animal practice 1997, 813-829. Churchill Livingstone, New York. 3rd edition. R.V. Morgan (Ed.).
18. Osweiler G., Carson T.L. Household drugs. The handbook of small animal practice 1997, 1279-1283. Churchill Livingstone, New York. 3rd edition. R.V. Morgan (Ed.).
19. Villar D., Buck W.B. Ibuprofen, aspirin, and acetaminophen toxicosis and treatment in dogs and cats. Vet Hum Toxicol 1998, 40:156-162.
20. Smith K.J., Taylor D.H. Another case of gastric perforation associated with administration of ibuprofen in a dog. JAVMA 1993, 202:706.
21. Spyridakis L.K., Bacia J.J., Barsanti J.A., et al. Ibuprofen toxicosis in a dog. JAVMA 1986, 188:918-919.
22. Adams S.S., Bough R.G., Cliffe E.E., et al. Absorption, distribution and toxicity of ibuprofen. Toxicol Appl Pharmacol 1969, 15:310-330.
23. Richardson J.A. Management of acetaminophen and ibuprofen toxicoses in dogs and cats. Vet Emerg Crit Care 2000, 10:285-291.
24. Rumbeiha W.K. Nephrotoxins. Kirk's current veterinary therapy XIII. Small animal practice 2000, 212-217. W.B. Saunders Co, Philadelphia. J.D. Bonagura (Ed.).
25. Owens-Clark J., Dorman D.C. Toxicity from newer over the counter drugs. Kirk's current veterinary therapy XIII. Small animal practice 2000, 227-231. W.B. Saunders Co, Philadelphia. J.D. Bonagura (Ed.).
26. Richardson J.A., Balabuszko R.A. Ibuprofen ingestion in ferrets: 43 cases (January 1996-March 2000). J Vet Emerg Crit Care 2001, 11:53-59.
27. Cathers T.E. Acute ibuprofen toxicosis in a ferret. JAVMA 2000, 216:1426-1428.
28. Rumack BH, editor. Aspirin (toxicologic managements). Poisindex System Vol 100. Englewood (CO): Micromedex. Expires 9/2000.
29. Booth D.M. The analgesic-antipyretic-antiinflammatory drugs. Veterinary and pharmacology and therapeutics 1995, 432-439. Iowa State University Press, Ames (IA). 7th edition. A.H. Richard (Ed.).
30. Plumb D.C. Veterinary drug handbook 1999, 56-58. Iowa State University Press, Ames (IA), 221, 434, 462, 518-9, 562, 583. 3rd edition.
31. Brogden R.N., Heel R.C., Speight T.M., et al. Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states. Drugs 1979, 18:241-277.
32. Brogden R.N., Pinder R.M., Sawer P.R., et al. Naproxen: a review of its pharmacological properties and therapeutic efficacy and use. Drugs 1975, 9:326-363.
33. Gfeller R.W., Sandors A.D. Naproxen-associated duodenal ulcer complicated by perforation and bacteria- and barium sulfate-induced peritonitis in a dog. JAVMA 1991, 198:644-646.
34. Gilmour M.A., Walshaw R. Naproxen-induced toxicosis in a dog. JAVMA 1987, 191:1431-1432.
35. Roudebush P., Morse G.E. Naproxen toxicosis in a dog. JAVMA 1981, 179:805-816.
36. Steel R.J.S. Suspected naproxen toxicity in dogs. Aust Vet J 1981, 57:100-101.
37. Hallesy D., Shott L., Hill R. Comparative toxicology of naproxen. Scand J Rheumatol Suppl 1973, 2:20-28.
38. Dye T.L. Naproxen toxicosis in a puppy. Vet Hum Toxicol 1997, 39:157-159.
39. Daehler M.H. Transmural pyloric perforation associated with naproxen administration in a dog. JAVMA 1986, 189:694-695.
40. Dean S.P., Reid J.F.S. Use of naproxen [letter]. Vet Rec 1985, 116:479.
41. Smith R.E. Naproxen toxicosis [letter]. JAVMA 1982, 180:107.
42. Shiltz R.A. Naproxen in dogs and cats [letter]. JAVMA 1982, 180:1397.
43. Deramaxx (Decracoxib) package insert 2011, Novartis Animal Health, US Inc., Greensboro (NC), NADA # 141-203, approved by FDA, Accessed January 10, 2012. http://valleyvet.naccvp.com/index.php?m=product_view_basic%26u=country%26p=msds%26id=1131012.
44. The Merck veterinary manual 2010, 2313-2328. Anti-inflammatory agents, Merck & Co, New Jersey. 10th edition. M. Kahn Cynthia (Ed.).
45. Plumb D.C. Veterinary drug handbook 2005, 222. Blackwell Publishing, Ames (IA). 5th edition.
46. Freedom of information summary new animal drug application Metacam® (meloxicam) 0.5 mg/mL and 1.5 mg/mL oral suspension. 2003 Boehringer Ingelheim Vetmedica, Inc., NADA 141-219, Accessed January 10, 2012. http://www.fda.gov/downloads/animalveterinary/products/approvedanimaldrugproducts/foiadrugsummaries/ucm118026.pdf.
47. Kirchner T., Argentieri A., et al. Evaluation of the anti-inflammatory activity of a duel cyclooxygenase-2 selective/5-lipoxygenaxe inhibitor, RWJ 63556, in a canine model of inflammation. J Pharmacol Exp Ther 1997, 282:1094-1101.
48. Blower P. Nabumetone: the science - equivalent efficacy and diminished risk. Eur J Rheumatol Inflamm 1991, 11:29-37.
49. Haddock R.E., Jeffery D.J., Lloyd J.A., et al. Metabolism of nabumetone by various species including man. Xenobiotica 1984, 14:327-337.
50. Mangan F., Flack J., Jackson D. Preclinical overview of nabumetone: pharmacology, bioavailability, metabolism, and toxicology. Am J Med 1987, 83:6-10.
51. Jackson D., Hardy T., Langley P., et al. Pharmacokinetic, toxicological, and metabolic studies with nabumetone. Proc. Symp. Held by BPUK Madera, 1983/R Soc. Med. Int. Congr. Symp. Ser 1985, (69).
52. Adams H.R. Veterinary pharmacology and therapeutics 1995, 443. Iowa State University Press, Ames (IA). 7th edition.
53. McKellar Q.A., Lees P., May S.A. Pharmacology and therapeutics of non-steroidal anti-inflammatory drugs in the dog and cat: 2 individual agents. J Small Anim Pract 1991, 32:225-235.
54. Boothe D. Analgesia/anti-inflammatories. CVMA 1997, 13-20. June.
55. Piroxicam. American Hospital Formulary Service drug information 2000, 1815. American Society of Healthsystem Pharmacists Inc., Bethesda (MD). G.K. McEvoy (Ed.).
56. Galbraith E.A., McKellar Q.A. Pharmacokinetics and pharmacodynamics of piroxicam in dogs. Vet Rec 1991, 128:561-565.
57. Thomas N.W. Piroxicam-associated gastric ulceration in a dog. Compend Small Anim Pract 1987, 9:1028-1030.
58. Diclofenac. American Hospital Formulary Service drug information 2000, 1800. American Society of Healthsystem Pharmacists Inc., Bethesda (MD). G.K. McEvoy (Ed.).
59. Stierlin H., Faigle J.W. Biotransformation of diclofenac sodium (Voltaren in animals and man: II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile. Xenobiotics 1979, 9:611-621.
60. Stierlin H., Faigle J.W., et al. Biotransformation of diclofenac sodium (Voltaren) in animals and in man: I. Isolation and identification of principal metabolites. Xenobiotics 1979, 9:601-610.
61. Diclofenac. In: RTECS: Registry of Toxic Effects of Chemical Substances. Cincinnati (OH): National Institute for Occupational Safety and Health. CD-ROM. MICROMEDEX, Greenwood Village (CO). Expires 7/02.
62. Indomethacin. American Hospital Formulary Service drug information 2001, 1924-1934. American Society of Healthsystem Pharmacists Inc., Bethesda (MD). G.K. McEvoy (Ed.).
63. Etodolac. American Hospital Formulary Service drug information 2001, 1913-1914. American Society of Healthsystem Pharmacists Inc., Bethesda (MD). G.K. McEvoy (Ed.).
64. Mathews K.A. Nonsteroidal anti-inflammatory analgesics: indications and contraindications for pain management in dogs and cats. Vet Clin N Am Sm Anim Pract 2000, 30:783-804.
65. Budsberg S.C., Johnston S.A., et al. Efficacy of etodolac for the treatment of osteoarthritis of the hip joints in dogs. JAVMA 1999, 214:206-210.
66. Reimer M.E., Johnston S.A., et al. The gastroduodenal effects of buffered aspirin, carprofen, and etodolac in healthy dogs. J Vet Intern Med 1999, 13:472-477.